Bayer AG’s shares have taken a hit since three consecutive U.S. juries awarded more than $2 billion in damages to cancer patients alleging that the…
Bayer AG’s shares have taken a hit since three consecutive U.S. juries awarded more than $2 billion in damages to cancer patients alleging that the…